[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334057-105":59,"doc-detail-334057-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","factors-influencing-in-hospital-mortality-in-cancer-patients-with-covid-19-retrospective-survival-analysis","Factors influencing in-hospital mortality in cancer patients with COVID-19 - retrospective survival analysis","","Evaluate survival among patients with COVID-19 and cancer and identify determinants of early in-hospital mortality. A retrospective cohort was drawn from a referral-center registry in Bogotá. Survival was compared by neoplasm type using Kaplan–Meier methods, and Cox regression assessed variables linked to higher death risk. Two hundred fifty-four patients were included, with frequent cardiovascular comorbidity and worse survival in solid tumors than hematologic malignancies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/factors-influencing-in-hospital-mortality-in-cancer-patients-with-covid-19-retrospective-survival-analysis/334057/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/factors-influencing-in-hospital-mortality-in-cancer-patients-with-covid-19-retrospective-survival-analysis/334057.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective regarding COVID-19 and cancer patients?","Question",{"text":112,"@type":113},"To evaluate survival in patients with COVID-19 and cancer and identify factors associated with early mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were survival outcomes analyzed and which statistical method was used for risk factors?",{"text":117,"@type":113},"Survival was analyzed by neoplasm type using Kaplan–Meier methods, and Cox regression was used to identify factors associated with higher death risk.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were significantly associated with higher in-hospital mortality?",{"text":121,"@type":113},"Higher C-reactive protein levels, higher Charlson’s comorbidity index, and respiratory failure were significantly associated with increased mortality.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334057,1791024313,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Factors influencing in-hospital mortality in cancer patients with COVID-19: A retrospective survival analysis  \nSandra Brigitte Amado-Garzón 1,2, Luisana Molina-Pimienta 1,2, Juan Manuel Vásquez-Jiménez 1,2, Karen Lizeth Álvarez-Raigoza 1,2, Mauricio Manrique-Samer 1,2, Carlos E Lombo-Moreno 1,2 and Alejandra Cañas-Arboleda 1,2  \nSAGE Open Medicine Volume 12: 1–10 © The Author(s) 2024 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/20503121241295852](DOI: 10.1177/20503121241295852)[ ](DOI: 10.1177/20503121241295852)[journals.sagepub.com/home/smo](journals.sagepub.com/home/smo)  \nAbstract  \nObjective: The aim of this study was to evaluate survival in patients with COVID-19 and cancer, and to find factors associated with early mortality.  \nMethods: Retrospective cohort derived from a registry of a referral center in Bogotá. Survival was analyzed according to the type of neoplasm using Kaplan–Meier method. A cox regression was performed to look for factors associated to higher risk of death.  \nResults: Two hundred fifty-four patients were included with cancer and COVID-19, most of whom were women (median age 68 years; range 19–97). Cardiovascular comorbidities were frequent. Patients with hematologic neoplasms had higher survival than those with solid neoplasms (log-rank test, p = 0.024). C-reactive protein levels (hazard ratio 1.02; 95% confidence interval 1.00–1.03, p = 0.025), Charlson’s comorbidity index (hazard ratio 1.15; 95% confidence interval 1.06–1.26, p = 0.004) and respiratory failure (hazard ratio 4.83; 95% confidence interval 2.47–9.44, p = \u003C0.001) were significantly associated with higher mortality. No interaction between active anticancer therapy and mortality was observed.  \nConclusion: In contrast to other reports, survival was worse in patients with solid tumors than in those with hematologic neoplasms. Increased C-reactive protein, Charlson’s comorbidity index and respiratory failure were associated with higher in-hospital mortality. This study reveals the complex impact of cancer and its treatment on COVID-19 outcomes, highlighting the persistent risks to cancer patients. It emphasizes monitoring C-reactive protein levels, comorbidities, and respiratory failure as key indicators of poor prognosis. Furthermore, we provide new insights into the differential impact of COVID-19 on cancer patients with solid organ versus hematologic neoplasms.  \nKeywords  \nCOVID-19, mortality, cancer, hematologic, neoplasm  \nDate received: 27 June 2024; accepted: 30 August 2024  \nIntroduction  \nThe COVID-19 pandemic has had a profound economic and social impact worldwide. By the end of 2022, 636 million cases were reported, with nearly 6.61 million deaths.1 Morbidity and mortality due to COVID-19 differs substantially depending on factors such as age and underlying comorbidities.2 Since the dawn of the pandemic, it was recognized that cancer patients were disproportionately affected, with higher risk of severe COVID-19 (i.e., intensive care unit (ICU) admission and/or death) compared to the general population (39% versus 8%, respectively),3 as well as delaysin oncologic treatment and research.4 However, this is a  \nhighly heterogeneous population, and the risk seems to be determined by other associated factors as well. 1,2,4,5  \nFor instance, hematologic malignancies have been associated with risk of death of 33%–37%6,7 as well as higher ICU admission (26% versus 19%) and higher need for ventilatory  \n1 Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá, Colombia  \n2Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia  \nCorresponding author:  \nJuan Manuel Vásquez-Jiménez, Department of Internal Medicine, Hospital Universitario San Ignacio, Carrera 7 \\# 40-62, Bogotá 110231, Colombia. Email: [juan_vasquez@javeriana.edu.co](juan_vasquez@javeriana.edu.co)  \nCreative Commons Non Commercial CC B","cbCaitNy8l4bjami","https://ap.wps.com/l/cbCaitNy8l4bjami","pdf",797609,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study objective regarding COVID-19 and cancer patients?\",\"answer\":\"To evaluate survival in patients with COVID-19 and cancer and identify factors associated with early mortality.\"},{\"question\":\"How were survival outcomes analyzed and which statistical method was used for risk factors?\",\"answer\":\"Survival was analyzed by neoplasm type using Kaplan–Meier methods, and Cox regression was used to identify factors associated with higher death risk.\"},{\"question\":\"Which factors were significantly associated with higher in-hospital mortality?\",\"answer\":\"Higher C-reactive protein levels, higher Charlson’s comorbidity index, and respiratory failure were significantly associated with increased mortality.\"}]","Factors influencing in-hospital mortality in cancer patients with COVID-19 - retrospective survival analysis | PDF",1790005158,25]